• info@lifecarediabetescentre.com
  • 011796 73263
Team Photo

Contact

  • drshalini@lifecarediabetescentre.com
  • http://drshalinijaggi.com/

Dr Shalini Jaggi

Director & Sr. Consultant Diabetologist

PROFILE :

  1. Exclusively working in the field of Diabetes for last 15+ years.

  2. Fellow of the Royal College of Physicians(FRCP) London, Edinburgh & Glasgow.

  3. Fellow of the American College of Endocrinology (FACE) the USA

  4. Recipient of the national “Fellowship of the Research Society for the Study of Diabetes in India RSSDI” Award- 2016.

  5. Recipient of the national “Fellowship of Diabetes India” Award-2017.

  6. Recipient of the National “Diabetes Awareness & Initiative Award” - 2018. 

  7. Governing Council Member, Research Society for the Study of Diabetes in India (RSSDI- National Executive Committee).

  8. Governing Council Member, Diabetes in Pregnancy Study Group India- DIPSI

  9. Faculty & Tutor, Postgraduate Diploma in Diabetes, Cardiff University, UK 

  10. Faculty & Tutor, Postgraduate Diploma in Diabetes, University of South Wales, UK.

  11. Regional Course Director(India)- Mastercourse in Diabetes for Physicians, certified by Diabetes UK & RCGP,UK.

  12. Advisor, Women’s Interprofessional Network- American Diabetes Association.

  13. Reviewer for the International Journal of Diabetes in Developing Countries, India.

  14. Reviewer for Journal of Diabetology, India

  15. Joint Secretary & Executive Committee Member, RSSDI- Delhi Chapter.

  16. Medical Advisor- www.beatmysugar.com

  17. Faculty for National Diabetes Foot Education Programme and various other regions as well national level diabetes teaching programs.

  18. Active contributor as an author to various scientific articles and publications in reputed scientific journals and textbooks of national and international repute.

  19. Certified Trainer: CSII Insulin Pump & CGMS (Medtronic), FGM (Abbott).

  20. Instrumental in conducting Diabetes Awareness, Screening and Prevention Programmes at various MNCs as well as private and public sector corporates & organizations, NGOs, etc. Actively involved in live chat shows on diabetes on various TV channels such as India TV, Total TV, CNBC, Zee News, and Haryana News.

  21. Writing Skills- Active contributor of diabetes articles and tips from time to time to various national newspapers and magazines as well as ‘Times of India online’ and ‘healthmedup” websites. 

  22. Areas of special interest- Diabetes and Pregnancy, Diabetes in the young & Type 1 Diabetes.

 

Current Position Held:

  1. Sr Consultant Diabetologist & Director, Lifecare Diabetes Centre, New Delhi

  2. Consultant Diabetologist, Apollo Cradle Hospitals & Clinics, New Delhi


Work Experience 

  1. Ex-Consultant Diabetologist & Head, Dr. Mohans’ Diabetes Specialities Centre, New Delhi 

  2. Ex-Consultant Diabetologist & Incharge, Action Diabetes Centre, Sri Balaji Action Medical Institute, New Delhi 

  3. Ex-Consultant Diabetologist at MGS Hospital, New Delhi  

  4. Ex-Fellow Diabetologist, Dr.Mohan’s Diabetes Specialities Centre, Chennai

  5. Ex-PGMO, Cama and Albless Hospital, Mumbai

  6. Junior Resident, LNJP Hospital, Delhi

  7. Demonstrator, Subharati Medical College, Meerut, UP


Professional Qualifications :

S. No. 

Qualification

University

  1.  

MBBS

Dr. D Y Patil Med Col, Mumbai University

  1.  

Advanced Diploma in Hospital Administration

Inst of Health Care Administration, Chennai

  1.  

Fellowship in Diabetology

Dr.Mohan’s Diabetes Specialities Centre, Chennai

  1.  

ICH GCP Certificate Programme in Clinical Research for Medical Practitioners

Cliniminds, Chennai

  1.  

Diabetes Observership

Joslin Diabetes Centre,Boston, USA

  1.  

PG Diploma in Diabetes 

Cardiff University, UK

  1.  

Advance Diabetes Certificate Course (India)

Steno Diabetes Centre, Denmark

  1.  

PG Diploma in Endocrinology

Univ of South Wales, UK

  1.  

Diabetes Observership

Diabetes &Endocrinol Centre of WestNew York, The State Univ of New York, Buffalo, USA

  1.  

Fellowship of the Royal College of Physicians (FRCP)

Edinburgh

  1.  

Fellowship of the Royal College of Physicians (FRCP)

Glasgow

  1.  

Fellowship of the American College of Endocrinology(FACE)

USA

  1.  

Fellowship of the Royal College of Physicians (FRCP)

London 


 

Scientific Publications: Textbook chapters/books  

Books as Author /co-author 

  1. RSSDI UPDATE 2018. Jaypee Brothers Medical Publishers, 2018.

  2. Novel Insights into SGLT2 Inhibitors, 1st edition. Jaypee Brothers Medical Publishers, 2019. 

Textbook Chapters As author/ Co-author 

  1. Jaggi S, Chawla R, Chawla A. Bionic Pancreas. In: Pareek KK, Wander GS, editors.Progress in Medicine (Medicine Update 2016); A Textbook of the Association of Physicians of India (API) and Indian College of Physicians(ICP). Chapter 23, Vol 26 (1). India: JaypeeBrothers Medical Publishers, 2016.

  2. Jaggi S. Siphoning blood glucose: A novel therapy. In: Chawla R, editor. Recent Advances in Diabetes. 1st ed. India: Jaypee Med Brothers Publishers, 2019.

  3. Jaggi S, Sehra S. Gestational Diabetes Mellitus. In: Mohan V, Unnikrishnan R, editors. Diabetes Clinical Case Series-2. 1st ed. India: Jaypee Brothers Med Publishers, 2018.

  4. Chawla R, Jaggi S. Insulin Therapy in Pregnancy: Initiation, Titration and Safety Update.In: Saxena P, editor. Clinical Guidelines for Management of Diabetes in Pregnancy, FOGSI. 1st ed. India: Jaypee Publishers; 2018.

  5. Tripathi K, Jaggi S, Gupta A. History of Diabetes. In: Tripathi K, Saboo B, editors. Sadikot’s International Textbook of Diabetes. 1st ed. India: Jaypee Publishers; 2019.

  6. Chawla R, Jaggi S, Chawla A. Medical Management of Hyperglycemia in Type 1 Diabetes Mellitus in Girls. In: Bajaj S, editor. Diabetes Mellitus:  Issues for the Indian Woman. 1st ed. India: Jaypee Brothers Medical Publishers, 2018.

  7. Chawla R. Jaggi S. GLP-1 Analogues: Benefits beyond glycemic control. in API Medicine Update, Chapter 40, Vol 28. India: Evangel Publishers, 2018.

  8. Jaggi S. SGLT-2 Inhibitors- A clinical review. In: Chawla R, editor. Handbook of Diabetes. 1st ed. India: Jaypee Brothers Med Publishers; 2018

  9. Jaggi S, Chawla R, Chawla A. Bionic Pancreas. In: Chawla R, editor. Recent Advances in Diabetes. 1st ed. India: Jaypee Med Brothers Publishers, 2019.

  10. Chawla A, Chawla R, Jaggi S. Microvascular, and Macrovascular Complications in Diabetes Mellitus: Distinct or Continuum? In: Chawla R, editor. Recent Advances in Diabetes. 1st ed. India: Jaypee Med Brothers Publishers, 2019.

  11. Jaggi S, Chawla R. Management of Inpatient Hyperglycemia.In: Tripathi K, Saboo B, editors. Sadikot’s International Textbook of Diabetes. 1st ed. India: Jaypee Publishers; 2018.

  12. Chawla R, Jaggi S. Biosynthesis, Secretion and Action of Glucagon In Tripathi K, Saboo B, editors. Sadikot’s International Textbook of Diabetes. 1st ed. India: Jaypee Publishers; 2018.

  13. Jaggi S.Case Study- Pioglitazone use in the current scenario. India: El Sevier Publishers,2016.

  14. Chawla R, Jaggi S. Diabetic Ketoacidosis in ACP-ICP Monograph on Emergencies in Diabetes and Endocrine Diseases;2019

  15. Chawla R, Jaggi S. Chapter 14 Gut-Brain Link in Diabetes. In: Joshi S, editor. RSSDI Textbook of Diabetes Mellitus. 4th ed. India: Jaypee Brothers Med Publishers; 2018.

  16. Chawla R, Jaggi S. Chapter 10 Dysregulation of Alpha-cell function in Type 2 Diabetes. In: Joshi S, editor. RSSDI Textbook of Diabetes Mellitus. 4th ed. India: Jaypee Brothers Med Publishers; 2018.

  17. Jaggi S, Chawla R. Diabetic Ketoacidosis. In: Practice Pearls in Type 2 Diabetes Mellitus. Indian Perspective. 1st edition. India: MVD Healthcare Publishers; 2018.

  18. Jaggi S, Chawla R. Diabetic Ketoacidosis. Chapter 3 In Emergencies in Diabetes and Medicine. Evangel Publishers. 2018-19

  19. “Management of Diabetes in the 21st Century: Insulin Pump Therapy” – A case study profiler co-authored by Dr V Mohan. Circulated by Medtronic Minimed.

  20. Incretin therapies in  Diabetes Drugs authored by Prof Romesh Khandori

  21. Insulin Secretagogues: Non-sulfonylureas Glinides [Repaglinide. Nateglinide]-in Diabetes Drugs authored by Prof Romesh Khandori.Jaypee Publishers

  22. Jaggi S. GDM Diagnosis in Indian Context. In RSSDI Update 2019.

  23. Chawla R, Jaggi S. History of Insulin. Chapter 1 in Agarwal S, editor. RSSDI’s Insulin Monograph (A complete guide to Insulin Therapy). 1st edition 2020, Jaypee Brothers Medical Publishers, India.

  24. Jaggi S, Chawla R. Managing Patients on Steroids. Chapter 47 in Agarwal S, editor. RSSDI’s Insulin Monograph (A complete guide to Insulin Therapy). 1st edition 2020, Jaypee Brothers Medical Publishers, India.

  25. Jaggi S, Chawla R. Insulin as an Anti-Inflammatory Agent. In ICP-API Injectable Therapies for Diabetes Management, Evangel Publishers,2020

  26. Chawla R, Jaggi S. Medical Management of Diabesity. Chapter 74 in Joshi SR editor. RSSDI Textbook of Diabetes Mellitus. 4th Edition. Jaypee Publishers, India

  27. Makkar B, Jaggi S. Chapter 26. Obesity & Type 2 Diabetes Mellitus- Do we understand the connection? In Joshi SR editor. RSSDI Textbook of Diabetes Mellitus. 4th Edition. Jaypee Publishers, India.

  28. Jaggi S. Latent Autoimmune Diabetes in Young: The case of Twin Brothers. Case Study 3 in RSSDI Annual Case Book 2020 published by Knowledge Bridge Publishers, India.


 

Scientific Publications: Papers 

  1. Panikar V, Sosale A, Agarwal S et al. RSSDI Clinical Practice Recommendations for Management of In-patient Hyperglycemia-2016. Int J Diabetes Dev Ctries (Nov 2016) 36 (Suppl 1): S1-S21.

  2. Chawla A, Chawla R, Jaggi S. Microvascular and Macrovascular complications in diabetes mellitus: Distinct or continuum? IJEM 2016;20(4): 546-551.

  3. RSSDI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus, 2015.Int JDiabetes Dev Ctries(October 2015) 35 (Suppl 1): S1-S71

  4. RSSDI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus, 2017.Int JDiabetes Dev Ctries (March 2018) 38 (Suppl 1): S1-S115

  5. Sehra S, Jaggi S et al. Management of Sitagliptin and Metformin Combination Toxic Overdose. JAPI (Nov 2016); 64:80-81.

  6. Ghosal S, Sinha B, Majumder A et al. Consensus on “Basal Insulin in the management of Type 2 Diabetes: Which, When and How?” JAPI, July 2017: Vol 65, pp 51-62.

  7. Chawla R, Jaggi S. Algorithm of Management of Type2 Diabetes- India Specific. Cardiology Today (Nov-Dec 2017).Vol XX1(6): 230-235.

  8. Pathophysiology of Insulin Resistance. Jaggi S, Sehra S, Sehra D. JCD 2015;  2(1):6-9.

  9. Pioglitazone uses in India- Do we need to look again? Sehra D, Sehra S, Jaggi S , JIACM 16(2); 2015.

  10. Chawla A, Chawla R, Jaggi S. Hypoglycemia Prevention and Management- A Pragmatic Approach. Haryana Medical Journal, March 2017; 40(1): 30-33.

  11. Viswanathan V, Krishnan...Jaggi S et al. Insights on Medical Nutrition Therapy for Type 2 Diabetes Mellitus: An Indian Perspective. Adv Ther. 2019 Feb 7. doi: 10.1007/s12325-019-0872-8.

  12. Chawla R, Jaggi S. Implications of CVD –REAL 2 Study for Indian Diabetic Population. J Diabetol 2019;10: 57-61.

  13. Chawla R, Jaggi S. Medical Management of Diabesity. JAPI Dec 2019; Vol 67: 52-56.

  14. R Chawla, BM Makkar, S Aggarwal..S Jaggi ..et al. RSSDI Consensus recommendations on insulin therapy in the management of diabetes.Guidelines. Int J Diab Dev Countr. Published online:05 Nov 2019. https://doi.org/10.1007/s13410-019-00783-6.

  15. Chawla R, Madhu SV, Makkar BM and On behalf of the RSSDI-ESI Consensus Group*.RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020. Indian J Endocr Metab. 2020;24:1–122.

  16. RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020 Int J Diabetes Dev Ctries (Jan-March 2020) 40 (Supp l): S1-S122

  17. Anjana RM, Sastry NG, Ramuu M, Jaggi S, et al. The role of hydroxychloroquine in COVID-19: Where do we stand? J Diabetol 2020;11: 65-70.

  18. Ghosh S, Tiwaskar M, Chawla R, Jaggi S et al. Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2). Diabetes Ther       https://doi.org/10.1007/s13300-020-00880-4.

  19. Jethwani P, Saboo B, Jethwani L, Jaggi S et al. Use of Insulin Glargine during pregnancy: A review. Diabetes & Metab Syndr: Clin Research and Reviews 15(2021) 379-384. https://doi.org/10.1016/j.dsx.2021.01.012 

  20. Frequency of Interactions with a Digital Therapeutic Platform Improves Blood Glucose Control among Patients with Type 2 Diabetes Mellitus. Chawla R, Sosale A,...Jaggi S et al. EMBRAACE Conference Paper 2020. Endocrine Practice 26 (No. Supplement 2): 114.

  21. Chawla R, Sahu J, Punyani H, Jaggi S. Evaluation of platelet volume indices as predictive biomarkers of microvascular complications in patients with type 2 diabetes International Journal of Diabetes in Developing Countries (2021),41:89-93.

  22. Relationship between diabetic retinopathy microalbuminuria and other modifiable risk factors Primary Care Diabetes 2021 Feb 4; S1751-9918(21)00012-7.  DOI: 10.1016/j.pcd.2021.01.012

  23. Chawla, R., Makkar, B.M., Aggarwal, S. et al. RSSDI consensus recommendations on insulin therapy in the management of diabetes. Int J Diabetes Dev Ctries 39, 43–92 (2019). https://doi.org/10.1007/s13410-019-00783-6

  24. Correlation between Cortical Renal Thickness and Estimated Glomerular Filtration Rate in Diabetic Nephropathy Patients Journal of diabetology.org on Tuesday, September 1, 2020, IP: 122.179.231.101]


 

Scientific Publications: Posters  

  1. Jaggi S, Sehra S, Singh M. Evaluation of waist circumference as a simple, non-invasive anthropometric marker of insulin resistance in overweight and obese non-diabetic, non-hypertensive adults from North India. Abstract No. 2408-P. 16-D. Diabetes. ADA June 2016.

  2. Chawla R, Chawla A, Jaggi S et al. Evidence of Teneliglitpin as an add-on therapy- An initial Real World Experience ( I-TREAT). ADA 2016.

  3. Chawla A, Chawla R, Jaggi S. Vascular Continuum of Complications in Type 2 Diabetes Mellitus- A Decade of Time Frame Experience. Poster No. 266- In AACE 2016.

  4. Chawla A, Chawla R, Jaggi S, Singh D. Trained nurse operated telemedicine-based retinal examination- A novel cost-effective model for the developing world. Poster no. 333 at AACE 2016 

  5. Chawla R, Joshi S, Saboo B, Jaggi S et al. Evaluation of Teneligliptin across the Indian Urban Setting- An Initial Real World Experience (INITIATE): Late-Breaking poster no.1314-AACE 2016.

  6. Makkar BM, Harichandan N, Chawla R, Jaggi S et al. Prevalence of Vit D deficiency in Type 2 Diabetes patients in North Indian population and its correlation with diabetic complications and Co-morbidities. Poster No. 251. AACE- 2016.

  7. Weight reduction with a once-daily dose of Orlistat and Metformin. Makkar BM, Chawla R, Sharma JK, Jaggi S et al. Poster no. At AACE 2016. 

  8. Benefits of Extended-release Metformin: Systematic Review of the ongoing clinical trials-AACE 2016

  9. Chawla R, Thacker H....Jaggi S et al. Meta-Synthesis and Trends in Publication on Evidence-Based Medicine for Teneligliptin: A year in review. Accepted for publication in New Horizons in Clinical Case Reports 2017.

  10. Chawla R,..Jaggi S et al. The TRENDS Author group. Meta-Synthesis and Trends in Publication on Evidence Based Medicine for Teneligliptin: A year in review. Poster No. 253, Published in suppl of Endocrine Practice at AACE 2017. 

  11. Thacker H, Chawla R..Jaggi S et al. Meta-synthesis of the the Evidence Based Medicine for Teneligliptin: A Systematic Review of 14 Reports. The METER Study Group. Poster No 1302-P. ADA 2017.

  12. Chawla A, Chawla R, Jaggi S et al. Translating Evidence into Action in a Community Setting- A Model Approach across Diabetes Continuum(TEAM). P-1051.IDF 2017

  13. Chawla R, Chawla A, Jaggi S et al. Triple Marker of HbA1c, BP and Aortic Augmentation Index as a Useful Screening Tool for Standard Care Approach in T2DM (TRIUMPH). P-0651. IDF 2017.

  14. Sehra S, Jaggi S, Singh M. Comparative evaluation of various anthropometric measures of insulin resistance in overweight and obese adults from North India. J Family Med Prim Care 2018 Jan; 7(Suppl 1): S1-S68.

  15. Makkar BM, Sharma JK, Jaggi S et al. Low Prevalence of Peripheral Arterial Disease in T2 Diabetes Patients in North India. Poster No. 462-P. ADA 2018

  16. Trehan S, Jaggi S et al. The Association of Lipid abnormalities and Microalbuminuria in Patients with T2DM as a marker of Optimal Care- Real-World Perspectives. E-Poster No 597813. Published in Endocrine Practice AACE 2019

  17. Chawla A, Jaggi S et al. Clustered Metabolic Approach in T2DM as a Novel Tool for Risk Stratification. E-Poster. Published in Endocrine Practice AACE 2019

  18. Jaggi, Chawla R. Adopting an Affordable DDP-IV Inhibitor for Early Access to SGLT2-Inhibitors to Address Pathophysiological Defects- Results from the Continuity Care Programme. Published in Endocrine Practice AACE 2019.

  19. Correlation between cortical renal thickness and estimated glomerular filtration rate in diabetic nephropathy patients–AACE 2019

  20. Chawla R, Jaggi S, Chawla A et al. Improvement in the Glycemic control with Insulin Glargine 300U/ml- Real-World Effectiveness in Indian T2DM Patients IMPLY. E Poster EMBRAACE- Published in Endocrine Practice AACE 2020 

  21. Real-World Effectiveness and Tolerability of Remogliflozin in Uncontrolled  T2DM patents. REMUS. . E Poster EMBRAACE- Published in Endocrine Practice AACE 2020 

  22. Abnormal ABI in Association with Nephropathy is a risk factor for CAD in Type2 Diabetes Patients: A Retrospective Real-world Evidence Study in Indian Population. P-497. ADA. Published in Diabetes 2020 Jun;69 (Supplement 1):- https://doi.org/10.2337/db20-497-P


 

Major Activities:

  1. Jt. Course Director(India), MasterCourse in Diabetes for Physicians, Univ of South Wales- Learna Ltd certified by Diabetes UK & RCGP, UK.

  2. Governing Council Member, RSSDI (National)

  3. Jt Secretary, Executive Committee- RSSDI, Delhi Chapter.

  4. Scientific Co-ordinator, RSSDI National Conference, 2019

  5. Organising Secretary, DIPSI National Conference, 2020 &2021

  6. Faculty, Tutor and Delhi Course co-ordinator, Diabetes teaching workshops by University of South Wales, UK

  7. Faculty and Tutor, Diabetes teaching workshops by Cardiff University, UK

  8. Member, Organising Committee, DIPSI National Conference 2016.

  9. Member &Panelist, Expert panel on Diabetes- ASSOCHAM & Min of Health, Govt of India “National Diabetes Summit- 2014”.

  10. Faculty, Certified Diabetes teaching course by Harvard Med School for Physicians:  2013-14 and 2015-2016..

  11. Delhi Faculty, National Diabetes Educators Programme.2014-2017.

  12. Delhi Faculty, National Diabetes Foot Education Programme.

  13. Delhi Faculty, AACE-INDIA Diabetes Symposium- 2014 and 2015. 

  14. Guidelines drafting committee member- RSSDI National Guidelines on Management of Inpatient Hyperglycemia in India 2016.

  15. Guidelines drafting committee member-RSSDI National Guidelines on diabetes management- complications. 2015-16.

  16. Delhi Faculty- I-LEAD Prgm on Liraglutide by Novo Nordisk.

  17. Actively involved in Delhi RSSDI Chapter activities, member organizing committee RSSDI-2013 to 2019, Annual Conference at New Delhi. Member, Executive Council, Delhi Chapter 2015-current.

  18. Faculty and Speaker at various CMEs, reputed National conferences, etc on Diabetes all across India.

  19. Actively involved in numerous diabetes awareness camps and CMEs in various forums and programs, both at Chennai as well as in Delhi.

  20. Honored by Punjab Kesari Senior Citizens Club and various other NGOs for diabetes awareness camps for their members.

  21. Awarded 1st prize in All India Essay Writing and Quiz Competition organized by Rajiv Gandhi Memorial Trust in 1992.The prize is given by the then Prime Minister of India, Mr.P.V.Narasimha Rao, and special felicitation by Mrs. Sonia Gandhi.

  22. Winner of Ruby Christian Roll of Honour, St.Thomas’ School in 1992, awarded to the most outstanding student of the school’s outgoing batch.

  23. Member Advisory Board, KOL & Faculty for various train-the-trainer programs by various MNCs.

  24. National Faculty & Course Author – ABIDE Insulin Modules

  25. Active contributor to various newspapers, magazines as well as online media- both national as well as international- on articles related to diabetes screening, management, and prevention.